Latest Industry News

All

Biotech Breakthroughs and Challenges: Key Insights from Endpoints Weekly

Biotech Breakthroughs and Challenges: Key Insights from Endpoints Weekly

FDA Staffing Crisis: 5% Departure Rate Raises Concerns Over Drug and Biologics Safety

FDA Staffing Crisis: 5% Departure Rate Raises Concerns Over Drug and Biologics Safety

Volastra Therapeutics Unveils Groundbreaking Human Data for KIF18A Drug VLS-1488 at #ASCO25 Conference

Volastra Therapeutics Unveils Groundbreaking Human Data for KIF18A Drug VLS-1488 at #ASCO25 Conference

FDA Advisory Committee Endorses JN.1 COVID-19 Vaccine Boosters Amid New Approval Guidelines

FDA Advisory Committee Endorses JN.1 COVID-19 Vaccine Boosters Amid New Approval Guidelines

Unlocking Mental Wellness: How Self-Guided Apps Revolutionize Treatment and Cut Costs

Unlocking Mental Wellness: How Self-Guided Apps Revolutionize Treatment and Cut Costs

ReproNovo Raises $65 Million to Revolutionize Infertility Treatments: A Focus on Men and Women

ReproNovo Raises $65 Million to Revolutionize Infertility Treatments: A Focus on Men and Women

Stay up to date on the latest news

By pressing the Subscribe button, you confirm that you have read our Privacy Policy.

Biotech Breakthroughs and Challenges: Key Insights from Endpoints Weekly

Biotech Breakthroughs and Challenges: Key Insights from Endpoints Weekly

FDA Staffing Crisis: 5% Departure Rate Raises Concerns Over Drug and Biologics Safety

FDA Staffing Crisis: 5% Departure Rate Raises Concerns Over Drug and Biologics Safety

Volastra Therapeutics Unveils Groundbreaking Human Data for KIF18A Drug VLS-1488 at #ASCO25 Conference

Volastra Therapeutics Unveils Groundbreaking Human Data for KIF18A Drug VLS-1488 at #ASCO25 Conference

Email Us

info at arsenal-advisors.com

Headquarters

Cambridge, MA USA